Show simple item record

CLOFARABINE IN COMBINATION WITH HIGH-DOSE CYTARABINE AND LIPOSOMAL DAUNORUBICIN IN PEDIATRIC AML: RESULTS OF A PHASE 1 COMBINATION STUDY BY THE ITCC CONSORTIUM

dc.contributor.authorZwaan, CMen_US
dc.contributor.authorDworzak, Men_US
dc.contributor.authorKlingebiel, Ten_US
dc.contributor.authorRoessig, Cen_US
dc.contributor.authorLeverger, Gen_US
dc.contributor.authorStary, Jen_US
dc.contributor.authorde Bont, ESen_US
dc.contributor.authorNiemeyer, CMen_US
dc.contributor.authorKaspers, GJen_US
dc.contributor.authorBertrand, Yen_US
dc.contributor.authorRamnarain, Sen_US
dc.contributor.authorGhazaly, EAen_US
dc.contributor.authorReinhardt, Den_US
dc.date.accessioned2015-02-23T11:02:52Z
dc.date.accessioned2016-01-19T16:42:04Z
dc.date.issued2014-12en_US
dc.identifier.issn1545-5009en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/10799
dc.description.sponsorshipThis study was financially supported by Sanofi, and by the KiKa-foundation grant nr. 26.en_US
dc.format.extentS138 - S138en_US
dc.language.isoenen_US
dc.relation.replaceshttp://qmro.qmul.ac.uk/jspui/handle/123456789/6610
dc.relation.replaces123456789/6610
dc.titleCLOFARABINE IN COMBINATION WITH HIGH-DOSE CYTARABINE AND LIPOSOMAL DAUNORUBICIN IN PEDIATRIC AML: RESULTS OF A PHASE 1 COMBINATION STUDY BY THE ITCC CONSORTIUMen_US
dc.typeConference Proceeding
dc.rights.holder2014. American Society of Hematology
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343932100124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume61en_US


Files in this item

Thumbnail
Name:
Pediatric Bllod and Cancer_ITCC ...
Size:
15.60Kb
Format:
application/
Description:
Submitted version
View/Open

This item appears in the following Collection(s)

Show simple item record